<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Fidelity Short Duration High Income Fund Fidelity Advisor Short Duration High Income Fund: Class I — News on 6ix</title>
    <link>https://6ix.com/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i</link>
    <description>Latest news and press releases for Fidelity Short Duration High Income Fund Fidelity Advisor Short Duration High Income Fund: Class I on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 20 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i" rel="self" type="application/rss+xml" />
    <item>
      <title>Purepoint Uranium Announces Grant of Restricted Share Units</title>
      <link>https://6ix.com/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i/news/purepoint-uranium-announces-grant-of-restricted-share-units-9</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i/news/purepoint-uranium-announces-grant-of-restricted-share-units-9</guid>
      <pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - Purepoint Uranium Group Inc. (TSXV: PTU) (OTCQB: PTUUF) (&quot;Purepoint&quot; or the &quot;Company&quot;) approved the</description>
    </item>
    <item>
      <title>Via Renewables Announces a Redemption of 209,437 Shares of Its 8.75% Series a Fixed-To-Floating Rate Cumulative Redeemable Perpetual Preferred Stock</title>
      <link>https://6ix.com/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i/news/via-renewables-announces-a-redemption-of-209437-shares-of-its-875percent-series-a-fixed-to-floating-rate-cumulative-redeemable-perpetual-preferred-stock-54</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i/news/via-renewables-announces-a-redemption-of-209437-shares-of-its-875percent-series-a-fixed-to-floating-rate-cumulative-redeemable-perpetual-preferred-stock-54</guid>
      <pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
      <description>HOUSTON, TX / ACCESS Newswire / April 20, 2026 / Via Renewables, Inc. (&quot;Via Renewables&quot; or the &quot;Company&quot;) (NASDAQ:VIASP), an independent retail energy</description>
    </item>
    <item>
      <title>NXP Announces Redemption of 3.875% Senior Notes Due 2026</title>
      <link>https://6ix.com/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i/news/nxp-announces-redemption-of-3875percent-senior-notes-due-2026-23</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i/news/nxp-announces-redemption-of-3875percent-senior-notes-due-2026-23</guid>
      <pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
      <description>EINDHOVEN, The Netherlands, April 20, 2026 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) (&quot;NXP&quot;) announced today that its subsidiary, NXP B.V.,</description>
    </item>
    <item>
      <title>Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares</title>
      <link>https://6ix.com/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i/news/trevi-therapeutics-announces-closing-of-dollar173-million-underwritten-offering-and-full-exercise-by-underwriters-of-option-to-purchase-additional-shares-8</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-short-duration-high-income-fund-fidelity-advisor-short-duration-high-income-fund-class-i/news/trevi-therapeutics-announces-closing-of-dollar173-million-underwritten-offering-and-full-exercise-by-underwriters-of-option-to-purchase-additional-shares-8</guid>
      <pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
      <description>NEW HAVEN, Conn., April 20, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the</description>
    </item>
  </channel>
</rss>